Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex321e50e27.htm |
| 10-K - 10-K - Timber Pharmaceuticals, Inc. | bpmx-20170131x10k.htm |
| EX-31.2 - EX-31.2 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex3129e78bc.htm |
| EX-31.1 - EX-31.1 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex3110faf1f.htm |
| EX-23.1 - EX-23.1 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex23170d9ff.htm |
| EX-10.23 - EX-10.23 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex102379071.htm |
| EX-10.11 - EX-10.11 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex10117bf7f.htm |
| EX-3.5 - EX-3.5 - Timber Pharmaceuticals, Inc. | bpmx-20170131ex359e7e407.htm |
EXHIBIT 21.1
SUBSIDIARY OF BIOPHARMX CORPORATION
As of January 31, 2017, BioPharmx Corporation’s sole subsidiary was BioPharmx Inc., a Nevada corporation.